Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 18
2010 72
2011 100
2012 114
2013 139
2014 145
2015 177
2016 204
2017 174
2018 187
2019 142
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

1,317 results
Results by year
Filters applied: . Clear all
Page 1
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.
Chakraborty AA, Laukka T, Myllykoski M, Ringel AE, Booker MA, Tolstorukov MY, Meng YJ, Meier SR, Jennings RB, Creech AL, Herbert ZT, McBrayer SK, Olenchock BA, Jaffe JD, Haigis MC, Beroukhim R, Signoretti S, Koivunen P, Kaelin WG Jr. Chakraborty AA, et al. Science. 2019 Mar 15;363(6432):1217-1222. doi: 10.1126/science.aaw1026. Epub 2019 Mar 14. Science. 2019. PMID: 30872525
The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis.
Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T, Pötter S, Zhang Y, Chen CW, Mallano T, Liang R, Kagwiria R, Kreuter A, Pantelaki I, Bozec A, Abraham D, Rieker R, Ramming A, Distler O, Schett G, Distler JHW. Bergmann C, et al. Ann Rheum Dis. 2018 Jan;77(1):150-158. doi: 10.1136/annrheumdis-2017-211501. Epub 2017 Oct 25. Ann Rheum Dis. 2018. PMID: 29070530
Jumonji histone demethylases as emerging therapeutic targets.
Park SY, Park JW, Chun YS. Park SY, et al. Pharmacol Res. 2016 Mar;105:146-51. doi: 10.1016/j.phrs.2016.01.026. Epub 2016 Jan 24. Pharmacol Res. 2016. PMID: 26816087 Review.
Emerging Roles of JmjC Domain-Containing Proteins.
Accari SL, Fisher PR. Accari SL, et al. Int Rev Cell Mol Biol. 2015;319:165-220. doi: 10.1016/bs.ircmb.2015.07.003. Epub 2015 Aug 19. Int Rev Cell Mol Biol. 2015. PMID: 26404469 Review.
JARID1 Histone Demethylases: Emerging Targets in Cancer.
Harmeyer KM, Facompre ND, Herlyn M, Basu D. Harmeyer KM, et al. Trends Cancer. 2017 Oct;3(10):713-725. doi: 10.1016/j.trecan.2017.08.004. Epub 2017 Sep 12. Trends Cancer. 2017. PMID: 28958389 Free PMC article. Review.
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J. Sharma SV, et al. Cell. 2010 Apr 2;141(1):69-80. doi: 10.1016/j.cell.2010.02.027. Cell. 2010. PMID: 20371346 Free PMC article.
1,317 results
Jump to page
Feedback